100 Participants Needed

Brain Stimulation for Dyslexia

TF
Overseen ByTess Fotidzis, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method to enhance reading skills in adults with dyslexia through non-invasive brain stimulation. Researchers aim to determine if this technique improves reading more effectively than traditional methods. The study compares various brain stimulation types, including CCN real non-invasive brain stimulation intervention, RLN and CCN real non-invasive brain stimulation intervention, and RLN real non-invasive brain stimulation intervention, alongside a sham version to assess real effects. Right-handed, native English-speaking adults who struggle with reading may qualify for this trial. As an unphased trial, it offers a unique chance to contribute to groundbreaking research that could transform dyslexia treatment.

Will I have to stop taking my current medications?

The trial excludes participants who are taking psychotropic medications or medications known to increase the risk of seizures or strokes. If you are on such medications, you may need to stop taking them to participate.

What prior data suggests that this non-invasive brain stimulation protocol is safe for adults with dyslexia?

Research has shown that non-invasive brain stimulation, such as transcranial direct current stimulation (tDCS), is generally safe. In studies involving 745 children and teens across 35 trials, no serious side effects occurred during 6,587 sessions, indicating that the treatment is usually well-tolerated.

For both the RLN and CCN brain stimulation methods, past research has found positive effects on brain functions related to reading and language skills. These benefits include fewer epileptic seizures and improvements in balance and math skills. Additionally, transcranial random noise stimulation (tRNS) has demonstrated stronger effects than tDCS on language and learning abilities.

Overall, while this specific trial is new, evidence from other studies suggests these brain stimulation methods are safe for people.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for dyslexia because they use non-invasive brain stimulation, a method that directly targets specific brain areas involved in reading and language processing. Unlike traditional dyslexia interventions, which often focus on behavioral therapies and educational strategies, these treatments aim to enhance brain function through stimulation of the left dorsolateral prefrontal cortex and left angular gyrus. This approach has the potential to improve reading skills by directly modifying neural activity, offering a novel avenue for intervention. Additionally, the use of real versus sham stimulation allows for precise measurement of the treatment's effectiveness, potentially leading to faster and more targeted improvements in dyslexia management.

What evidence suggests that this trial's brain stimulation treatments could be effective for dyslexia?

Research has shown that non-invasive brain stimulation can help people with dyslexia improve their reading skills. In this trial, participants will receive different types of brain stimulation. The RLN and CCN brain stimulation methods, part of separate treatment arms in this trial, target brain areas involved in reading. Studies indicate that combining methods like transcranial direct current stimulation (tDCS) with reading exercises can enhance specific reading abilities, such as recognizing sounds in words. Additionally, tDCS has been linked to better reading speed and accuracy. Overall, these findings provide promising evidence that brain stimulation could be a useful tool for improving reading skills in individuals with dyslexia.13678

Who Is on the Research Team?

KS

Katherine S. Aboud, PhD

Principal Investigator

Vanderbilt University

Are You a Good Fit for This Trial?

This trial is for right-handed, native English-speaking adults aged 18-40 with dyslexia. Participants must not have a low IQ, developmental disorders, visual or hearing impairments that can't be corrected, metal devices in their body, recent migraines, severe fatigue or psychiatric issues. They should not be pregnant and mustn't take certain medications.

Inclusion Criteria

I am right-handed and only speak English.

Exclusion Criteria

I have a known neurological condition such as epilepsy or brain injury.
I have been recently diagnosed with migraines.
Hair styles that do not allow for proper EEG net fitting, or that pose potential risks for damage to EEG net
See 14 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Establish baseline behavior and brain measures of the individual

1 day
1 visit (in-person, 3.5 hours)

Intervention

Behavioral and non-invasive stimulation intervention, including MRI and EEG sessions

1 day
1 visit (in-person, 3 hours)

Follow-up Assessment

Establish prolonged intervention effects using behavior and brain measures

1 day
1 visit (in-person, 2.5 hours)

Long-term Follow-up

Participants are monitored for changes in reading comprehension and brain activations

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • CCN real non-invasive brain stimulation intervention
  • RLN and CCN real non-invasive brain stimulation intervention
  • RLN real non-invasive brain stimulation intervention
  • Sham intervention
Trial Overview The study tests the effect of non-invasive brain stimulation on reading comprehension in adults with dyslexia. It compares different types of stimulations (RLN and CCN) against a sham intervention to see which improves reading skills and brain function.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Reading and Language Network (RLN)Experimental Treatment1 Intervention
Group II: RLN and CCNExperimental Treatment1 Intervention
Group III: Sham stimulationPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University

Lead Sponsor

Trials
714
Recruited
6,143,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

A systematic review of 64 studies involving 2262 participants found that transcranial direct current stimulation (tDCS) has a low dropout rate (6% for active and 7.2% for sham), indicating good acceptability among participants.
Despite the low dropout rates, many studies inadequately reported adverse events (AEs), highlighting a need for improved guidelines to standardize AE reporting in tDCS research.
A Systematic Review on the Acceptability and Tolerability of Transcranial Direct Current Stimulation Treatment in Neuropsychiatry Trials.Aparício, LVM., Guarienti, F., Razza, LB., et al.[2018]
Eighteen children and adolescents with dyslexia underwent 18 sessions of transcranial direct current stimulation (tDCS) combined with cognitive training, resulting in significant improvements in reading low frequency words and non-words, with effects lasting one month after treatment.
The study found no adverse effects from the tDCS treatment, indicating it is a safe and feasible option for enhancing reading abilities in children and adolescents with dyslexia.
Evidence for reading improvement following tDCS treatment in children and adolescents with Dyslexia.Costanzo, F., Varuzza, C., Rossi, S., et al.[2018]
Non-invasive electrical brain stimulation (NEBS), particularly through techniques like transcranial direct current stimulation (tDCS) and transcranial random noise stimulation (tRNS), can effectively modulate brain function and improve motor skills in healthy individuals and patients with motor disabilities.
The article outlines a detailed protocol for applying tDCS to the primary motor cortex, discussing the benefits and drawbacks of different electrode placements, while also addressing safety and tolerability concerns associated with these stimulation methods.
Non-Invasive Electrical Brain Stimulation Montages for Modulation of Human Motor Function.Curado, M., Fritsch, B., Reis, J.[2018]

Citations

Brain Stimulation for Dyslexia... RLN real non-invasive brain stimulation intervention will have tolerable side effects & efficacy for patients with Dyslexia and Dyslexia. See if you qualify
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40466912/
A randomized, double-blind, controlled clinical trialThe present study aimed to investigate whether tDCS would enhance the reading skills of dyslexic children and whether the effect is long-lasting.
Comparing the Efficacy of tDCS and tRNS to Improve ...Transcranial electrical stimulation improves phoneme processing in developmental dyslexia. ... non-invasive brain stimulation. transcranial electrical stimulation.
On the Effects of Non-Invasive Brain Stimulation Techniques ...Conclusion: Research indicates that tDCS, when used with reading interventions, enhances specific reading skills in individuals with dyslexia. Additionally, ...
a scoping review Efficacy of Transcranial Direct Current ...This study aims to improve the existing knowledge about the application of Transcranial Direct Current Stimulation in rehabilitating Developmental Dyslexia.
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/35938945/
A systematic review of randomized controlled trials on ...tDCS was found safe with no reported serious side effects in 6587 sessions conducted on 745 children and adolescents across 35 studies.
Impact of Transcranial Direct Current Stimulation on ...Positive results after transcranial direct current stimulation include reduction of epileptic seizures, improvement in static balance and ...
Effects of online tDCS and hf-tRNS on reading ...Previous findings have shown stronger effects of tRNS compared to tDCS on language and learning abilities, including mathematical skills (69), as well as on ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security